CATHY COLLIER: Open Payments
NPI 1083886907 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 9 companies in 2025. Trend: 2023 $829 · 2024 $901 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $166 |
| PFIZER INC. | 5 | $72 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| ABIOMED | 1 | $34 |
| Boston Scientific Corporation | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: LEQVIO, ELIQUIS, VERQUVO, VersaCross Steerable Access Solution, SHINGRIX, ONPATTRO, Ozempic.
Industry payments across KY — which companies pay providers there.
